Related Experiment Video
Updated: Aug 11, 2026

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
Published on: January 27, 2019
The clinical immunology of human Chagas disease
Walderez O Dutra1, Manoel Otávio C Rocha, Mauro M Teixeira
1Department of Morfologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Avenida Antônio Carlos 6627, Belo Horizonte, Minas Gerais 31270-901, Brazil.
Insights
This review details the immunology of human Chagas disease, caused by Trypanosoma cruzi. It highlights the wide range of clinical symptoms and the need for standardized criteria in research.
Area of Science:
- Infectious Diseases
- Immunology
- Parasitology
Background:
- Chagas disease affects 17 million people in Latin America, caused by Trypanosoma cruzi.
- A significant portion of infected individuals develop clinical symptoms or abnormal test results.
- Clinical manifestations vary widely, from asymptomatic cases to severe cardiac issues.
Purpose of the Study:
- To conduct a systematic review of human Chagas disease immunology.
- To discuss recent immunological findings within a clinical context.
Main Methods:
- Systematic review of existing literature.
- Analysis of immunological data in human Chagas disease.
Main Results:
- The study synthesizes current knowledge on the immune response in Chagas disease.
- It emphasizes the correlation between immunological profiles and clinical outcomes.
- The review underscores the variability in disease presentation.
Conclusions:
- Standardized clinical criteria are essential for consistent research across different groups.
- Understanding Chagas disease immunology is crucial for managing its diverse clinical spectrum.
Abstract:
Human infection with the protozoan parasite Trypanosoma cruzi leads to Chagas disease, which affects approximately 17 million people in Latin America. A significant percentage of the infected population will develop clinical symptoms or present changes in laboratory and/or image evaluation. The existence of a large spectrum of clinical manifestations--with patients ranging from asymptomatic to severe cardiac involvement--emphasizes the need to use standardized and well-defined clinical criteria among different research groups. In this article, we carry out a systematic review of the immunology in human Chagas disease, discussing recent findings in the context of a clinical perspective.
More Related Videos
Related Concept Videos
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Leishmaniasis
Toxoplasmosis
American Trypanosomiasis
Trichomoniasis

